AAAAAA
Results: 51-65/65
Authors:
PETERS WP
ROSS M
VREDENBURGH J
HUSSEIN A
MEISENBERG B
GILBERT C
PETROS WP
KURTZBERG J
Citation: Wp. Peters et al., ROLE OF CYTOKINES IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Hematology/oncology clinics of North America, 7(3), 1993, pp. 737-747
Authors:
PETERS WP
ROSS M
VREDENBURGH JJ
MEISENBERG B
MARKS LB
WINER E
KURTZBERG J
BAST RC
JONES R
SHPALL E
WU K
ROSNER G
GILBERT C
MATHIAS B
CONIGLIO D
PETROS W
HENDERSON IC
NORTON L
WEISS RB
BUDMAN D
HURD D
Citation: Wp. Peters et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1132-1143
Authors:
PETROS WP
PETERS WP
Citation: Wp. Petros et Wp. Peters, COST IMPLICATIONS OF HEMATOPOIETIC GROWTH-FACTORS IN THE BMT SETTING, Bone marrow transplantation, 11, 1993, pp. 36-38
Authors:
BERLANGIERI SU
PETERS WP
COLEMAN RE
Citation: Su. Berlangieri et al., DISTRIBUTION OF TC-99M-SULFUR COLLOID DURING GRANULOCYTE-COLONY-STIMULATING FACTOR ADMINISTRATION IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Nuclear medicine communications, 14(10), 1993, pp. 896-901
Authors:
ANSCHER MS
PETERS WP
REISENBICHLER H
PETROS WP
JIRTLE RL
Citation: Ms. Anscher et al., TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER, The New England journal of medicine, 328(22), 1993, pp. 1592-1598
Authors:
HUSSEIN A
ROSS M
VREDENBURGH J
MEISENBERG B
GILBERT C
PETROS W
CONIGLIO D
KURTZBERG J
PETERS WP
Citation: A. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000293-10000293
Authors:
MODLIN C
PETROS WP
STUART AR
GUPTON C
RABINOWITZ J
PETERS WP
Citation: C. Modlin et al., RECOMBINANT HUMAN IL-1-BETA ADMINISTRATION FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) PRODUCES DOSE-DEPENDENT INCREASES IN ENDOGENOUS CYTOKINE CONCENTRATIONS, Blood, 82(10), 1993, pp. 10000306-10000306
Authors:
VREDENBURGH JJ
WATERSPICK B
KURTZBERG J
DRAGO S
ROSS M
HUSSEIN A
PETERS WP
Citation: Jj. Vredenburgh et al., A SINGLE 6-HOUR (HR) STEADY-STATE LEUKAPHERESIS IS SUFFICIENT FOR COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AFTER G-CSF, Blood, 82(10), 1993, pp. 10000349-10000349
Authors:
MURASE T
ANSCHER M
PETROS WP
PETERS WP
JIRTLE RL
Citation: T. Murase et al., KINETICS OF PLASMA TGF-BETA AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER, Blood, 82(10), 1993, pp. 10000430-10000430
Authors:
GUPTON C
PETROS WP
RABINOWITZ J
MODLIN C
STUART AR
PETERS WP
Citation: C. Gupton et al., CONCENTRATIONS OF SOLUBLE TNF RECEPTORS (STNFR) AND IL-1 RECEPTOR ANTAGONIST (IL-1RA) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Blood, 82(10), 1993, pp. 10000430-10000430
Authors:
CARTEE L
PETROS WP
ROSNER G
GILBERT C
MOORE S
AFFRONTI M
HOKE J
PETERS WP
Citation: L. Cartee et al., EVALUATION OF GM-CSF MOUTHWASH FOR PREVENTION OF CHEMOTHERAPY-INDUCEDMUCOSITIS - A RANDOMIZED, DOUBLE-BLIND, DOSE-ESCALATING STUDY, Blood, 82(10), 1993, pp. 10000496-10000496
Authors:
LEE R
HUSSEIN A
PLUMER M
PETROS WP
PETERS WP
Citation: R. Lee et al., PULMONARY DRUG TOXICITY (PDT) FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND CARMUSTINE (CPB) WITH AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) SUPPORT IN PRIMARY HIGH-RISK BREAST-CARCINOMA WITH 10 OR MORE AXILLARY LYMPH-NODES, Blood, 82(10), 1993, pp. 10000634-10000634
Authors:
PETERS WP
ROGERS MC
Citation: Wp. Peters et Mc. Rogers, VARIATION IN APPROVAL OF PRIVATE HEALTH-INSURANCE COVERAGE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER, Blood, 82(10), 1993, pp. 10000639-10000639
Authors:
RABINOWITZ J
PETROS WP
STUART AR
PETERS WP
Citation: J. Rabinowitz et al., CHARACTERIZATION OF ENDOGENOUS CYTOKINE CONCENTRATIONS AFTER HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT, Blood, 81(9), 1993, pp. 2452-2459
Authors:
TODD NW
PETERS WP
OST AH
ROGGLI VL
PIANTADOSI CA
Citation: Nw. Todd et al., PULMONARY DRUG TOXICITY IN PATIENTS WITH PRIMARY BREAST-CANCER TREATED WITH HIGH-DOSE COMBINATION CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, The American review of respiratory disease, 147(5), 1993, pp. 1264-1270